This inventor holds 9 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 4 EPO patents. Top assignees: Novartis Ag, University of Pennsylvania, Sunshine Lake Pharma Co., Ltd.. Active years: 2015-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Dongguan, CN (2015)
- Shanghai, CN (2017 - 2023)
Company Filing History:
8 out of 3,978 
8 out of 2,663 
1 out of 119 Years Active: 2015-2025
Title: Jiquan Zhang: Innovator in Cancer Treatment
Introduction
Jiquan Zhang is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of cancer treatment through his innovative research and development of chimeric antigen receptors (CARs). With a total of 9 patents, Zhang's work focuses on advancing therapeutic options for patients suffering from various cancers.
Latest Patents
Zhang's latest patents include groundbreaking inventions aimed at treating cancer. One notable patent is for the treatment of cancer using a CD33 chimeric antigen receptor. This invention provides compositions and methods for treating diseases associated with the expression of CD33. It also relates to a CAR specific to CD33, vectors encoding the same, and recombinant T cells that comprise the CD33 CAR. Additionally, the invention includes methods for administering genetically modified T cells expressing a CAR with a CD33 binding domain. Another significant patent involves the treatment of cancer using a CD123 chimeric antigen receptor. This invention offers compositions and methods for treating diseases associated with the expression of CD123, along with a CAR specific to CD123, vectors encoding it, and recombinant cells that comprise the CD123 CAR. It also includes methods for administering genetically modified cells expressing a CAR with a CD123 binding domain.
Career Highlights
Throughout his career, Jiquan Zhang has worked with notable organizations, including Novartis AG and the University of Pennsylvania. His experience in these prestigious institutions has allowed him to collaborate with leading experts in the field and contribute to significant advancements in cancer research.
Collaborations
Zhang has collaborated with esteemed colleagues such as Qilong Wu and Jennifer Brogdon. These partnerships have further enhanced his research and development efforts, leading to innovative solutions in cancer treatment.
Conclusion
Jiquan Zhang's contributions to cancer treatment through his innovative patents and collaborations highlight his dedication to improving patient outcomes. His work continues to pave the way for advancements in the field of oncology.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile